These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8619009)

  • 1. GM1 ganglioside administration partially counteracts the morphological changes associated with haloperidol treatment within the dorsal striatum of the rat.
    Meshul CK; Stallbaumer RK; Allen C
    Psychopharmacology (Berl); 1995 Oct; 121(4):461-9. PubMed ID: 8619009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment.
    Meshul CK; Buckman JF; Allen C; Riggan JP; Feller DJ
    Synapse; 1996 Apr; 22(4):350-61. PubMed ID: 8867029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity.
    Meshul CK; Tan SE
    Synapse; 1994 Nov; 18(3):205-17. PubMed ID: 7855733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses.
    Meshul CK; Bunker GL; Mason JN; Allen C; Janowsky A
    J Neurochem; 1996 Nov; 67(5):1965-73. PubMed ID: 8863502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.
    Meshul CK; Andreassen OA; Allen C; Jørgensen HA
    Psychopharmacology (Berl); 1996 Jun; 125(3):238-47. PubMed ID: 8815959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses.
    Meshul CK; Stallbaumer RK; Taylor B; Janowsky A
    Brain Res; 1994 Jun; 648(2):181-95. PubMed ID: 7922533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion.
    Meshul CK; Allen C
    Synapse; 2000 May; 36(2):129-42. PubMed ID: 10767060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
    Robinson S; Krentz L; Moore C; Meshul CK
    Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.
    Meshul CK; Emre N; Nakamura CM; Allen C; Donohue MK; Buckman JF
    Neuroscience; 1999 Jan; 88(1):1-16. PubMed ID: 10051185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of haloperidol and SCH-23390 prevents the increase in "perforated" synapses due to either drug alone.
    Meshul CK; Janowsky A; Casey DE; Stallbaumer RK; Taylor B
    Neuropsychopharmacology; 1992 Dec; 7(4):285-93. PubMed ID: 1476593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover.
    Vital MA; Flório JC; Frussa-Filho R; De Lucia R; Tufik S; Palermo-Neto J
    Life Sci; 1998; 62(13):1161-9. PubMed ID: 9519797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment.
    Agnati LF; Fuxe K; Benfenati F; Battistini N; Zini I; Toffano G
    Neurosci Lett; 1983 Oct; 40(3):293-7. PubMed ID: 6646502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of striatal glutamatergic system in haloperidol-induced dopamine receptor supersensitivity and effects of monosialoganglioside GM1.
    Schroeder H; Schroeder U; Sabel BA
    Pharmacol Biochem Behav; 1997 Dec; 58(4):903-7. PubMed ID: 9408194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens, and medial prefrontal cortex.
    Meshul CK; Janowsky A; Casey DE; Stallbaumer RK; Taylor B
    Psychopharmacology (Berl); 1992; 106(1):45-52. PubMed ID: 1531388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration.
    Andreassen OA; Meshul CK; Moore C; Jørgensen HA
    Psychopharmacology (Berl); 2001 Aug; 157(1):11-9. PubMed ID: 11512038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.
    Roberts RC; Force M; Kung L
    Synapse; 2002 Aug; 45(2):78-85. PubMed ID: 12112400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity.
    Burrows KB; Meshul CK
    Neuroscience; 1999 Mar; 90(3):833-50. PubMed ID: 10218784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats.
    See RE; Chapman MA
    Eur J Pharmacol; 1994 Oct; 263(3):269-76. PubMed ID: 7843264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.